( Tuberculosis remains a major global hea...)Boosting The BCG Vaccine To Beat Tuberculosis

Tuberculosis remains a major global health threat. Although more than 3 billion doses of the BCG vaccine have been administered to fight tuberculosis, the ability of the BCG vaccine to protect adults is very limited, as is its efficacy against newly emerging isolates.

In a study appearing online on August 18 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation, Stefan Kaufmann and colleagues from the Max Planck Institute devise a strategy to boost the immunogenicity of BCG and describe a novel vaccine strain with high efficacy against tuberculosis. The researchers engineer a BCG strain that secretes the listeriolysin protein, which punches holes in the membranes of phagosomes where M. tuberculosis is located, allowing better T cell-mediated immunity. Because listeriolysin works optimally at a pH of 5.8, the researchers also deleted the urease C gene of BCG, which normally plays a role in pH neutralization of the phagosome. The lack of urease C allows phagosomal acidification and provides an ideal pH environment for listeriolysin.

The new BCG vaccine strain protects mice against tuberculosis significantly better than the parental BCG. Superior protection is not only induced against the laboratory strain of M. tuberculosis but also against a clinical isolate of the Beijing/W family, a straing of tuberculosis that is spreading all over the world, is drug-resistant, and is responsible for the most threatening disease outbreaks.

'"/>

Source:JCI


Page: 1
Related biology news :

1. Boosting HIV screening can increase survival and is cost effective
2. Boosting newborns immune responses
3. Boosting brain power -- with chocolate
4. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
5. Live Recombinant Adenovirus Vaccine Technique Explored
6. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
7. NIAID Initiates Trial of Experimental Avian Flu Vaccine
8. Study Models Impact Of Anthrax Vaccine
9. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
10. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
11. EuroVacc 02 HIV Vaccine Trial Begins